微流體市場報告:至2030年的趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356905

微流體市場報告:至2030年的趨勢、預測與競爭分析

Microfluidics Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

微流控趨勢和預測

預計到2030年,全球微流控市場將達到 655 億美元,2024年至2030年年複合成長率為 13.8%。市場的主要驅動力是分析和臨床研究活動的增加,癌症、糖尿病和心血管疾病等慢性病的盛行率上升,以及對即時診斷的需求的增加。全球微流控市場前景廣闊,晶片實驗室、晶片器官、連續流微流控、光流控/微流控、聲流控/微流控、電泳/微流控等領域存在商機市場。

微流控市場洞察

  • Lucintel預測,由於醫療/保健在生物分析、化學合成和資訊技術領域發揮關鍵作用,因此預計在預測期內將出現高速成長。
  • 在這個市場中,晶片實驗室可能仍然是最大的細分市場,因為它具有在 7 分鐘內超快速檢測病毒和細菌的巨大潛力。
  • 由於醫療保健支出增加和政府機構研究經費增加,北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題:

  • Q.1.細分市場中最有前途和高成長的機會為何?
  • Q.2.哪個細分市場將以更快的速度成長?理由為何?
  • Q.3.哪些地區未來會出現更快的成長?理由為何?
  • Q.4.影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5.這個市場的商業風險和競爭威脅為何?
  • Q.6.這個市場有哪些新趨勢?理由為何?
  • Q.7.市場客戶需求有何改變?
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10.該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球微流控市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球微流控市場趨勢(2018-2023)與預測(2024-2030)
  • 依技術分類的全球微流體市場
    • 醫療/保健
    • 非醫療用途
  • 按材料分類的全球微流體市場
    • 玻璃
    • 聚合物
    • PDMS
    • 其他
  • 全球微流控市場的應用
    • 晶片實驗室
    • 器官晶片
    • 連續流微流體
    • 光流控和微流控
    • 聲流體學和微流體學
    • 電泳和微流體
    • 其他

第4章 2018-2030年市場趨勢及預測分析,依地區

  • 全球微流控市場,依區域
  • 北美微流控市場
  • 歐洲微流體市場
  • 亞太微流體市場
  • 其他區域微流體市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球微流體市場成長機會,依技術
    • 全球微流體市場成長機會,按材料
    • 全球微流體市場成長機會,依應用
    • 全球微流體市場成長機會,依地區
  • 全球微流控市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球微流體市場的產能
    • 全球微流體市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Illumina
  • F. Hoffmann-La Roche
  • PerkinElmer
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific
  • Standard BioTools
簡介目錄

Microfluidics Trends and Forecast

The future of the global microfluidics markets looks promising with opportunities in the lab-on-a-chip, organs-on-chips, continuous flow microfluidics, optofluidics and microfluidics, acoustofluidics and microfluidics, and electrophoresis and microfluidics markets. The global microfluidics markets is expected to reach an estimated $65.5 billion by 2030 with a CAGR of 13.8% from 2024 to 2030. The major drivers for this market are an increase in analytical and clinical research activities, rising prevalence of chronic diseases, such as cancer, diabetes and cardiovascular disease, and growing demand of point-of-care diagnostics.

A more than 150-page report is developed to help in your business decisions.

Microfluidics by Segment

The study includes a forecast for the global microfluidics by technology, material, application, and region.

Microfluidics Markets by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Medical/Healthcare
  • Non-medical

Microfluidics Markets by Material [Shipment Analysis by Value from 2018 to 2030]:

  • Silicon
  • Glass
  • Polymer
  • PDMS
  • Others

Microfluidics Markets by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Lab-on-a-chip
  • Organs-on-chips
  • Continuous Flow Microfluidics
  • Optofluidics and Microfluidics
  • Acoustofluidics and Microfluidics
  • Electrophoresis and Microfluidics
  • Others

Microfluidics Markets by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Microfluidics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies microfluidics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microfluidics companies profiled in this report include-

  • illumina
  • F. Hoffmann-La Roche
  • Perkinelmer
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific
  • Standard Biotools

Microfluidics Market Insights

  • Lucintel forecasts that medical/healthcare is expected to witness higher growth over the forecast period due to they play an important role in the fields of bioanalytical, chemical synthesis and information technology.
  • Within this market, lab-on-a-chip will remain the largest segment as it possess the great potential for ultra-fast virus and bacteria detection in seven minutes.
  • North America will remain the largest region over the forecast period due to increasing healthcare expenditure and growing funding for research by government agencies in the region.

Features of the Global Microfluidics Markets

  • Market Size Estimates: Microfluidics markets size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Microfluidics markets size by technology, material, application, and region. in terms of value ($B).
  • Regional Analysis: Microfluidics markets breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different technologies, materials, applications, and region.s for the microfluidics markets.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microfluidics markets.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the microfluidics markets size?

Answer: The global microfluidics markets is expected to reach an estimated $65.5 billion by 2030.

Q.2. What is the growth forecast for microfluidics markets?

Answer: The global microfluidics markets is expected to grow with a CAGR of 13.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the microfluidics markets?

Answer: The major drivers for this market are an increase in analytical and clinical research activities, rising prevalence of chronic diseases, such as cancer, diabetes and cardiovascular disease, and growing demand of point-of-care diagnostics.

Q.4. What are the major segments for microfluidics markets?

Answer: The future of the microfluidics markets looks promising with opportunities in the lab-on-a-chip, organs-on-chips, continuous flow microfluidics, optofluidics and microfluidics, acoustofluidics and microfluidics, and electrophoresis and microfluidics markets.

Q.5. Who are the key microfluidics markets companies?

Answer: Some of the key microfluidics companies are as follows:

  • illumina
  • F. Hoffmann-La Roche
  • PerkinElmer
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific
  • Standard BioTools

Q.6. Which microfluidics markets segment will be the largest in future?

Answer: Lucintel forecasts that medical/healthcare is expected to witness higher growth over the forecast period due to they play an important role in the fields of bioanalytical, chemical synthesis and information technology.

Q.7. In microfluidics markets, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing healthcare expenditure and growing funding for research by government agencies in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the microfluidics markets by technology (medical/healthcare and non-medical), material (silicon, glass, polymer, PDMs, and others), application (lab-on-a-chip, organs-on-chips, continuous flow microfluidics, optofluidics and microfluidics, acoustofluidics and microfluidics, and electrophoresis and microfluidics), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Microfluidics Markets : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Microfluidics Markets Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Microfluidics Markets by Technology
    • 3.3.1: Medical/Healthcare
    • 3.3.2: Non-medical
  • 3.4: Global Microfluidics Markets by Material
    • 3.4.1: Silicon
    • 3.4.2: Glass
    • 3.4.3: Polymer
    • 3.4.4: PDMS
    • 3.4.5: Others
  • 3.5: Global Microfluidics Markets by Application
    • 3.5.1: Lab-on-a-chip
    • 3.5.2: Organs-on-chips
    • 3.5.3: Continuous Flow Microfluidics
    • 3.5.4: Optofluidics and Microfluidics
    • 3.5.5: Acoustofluidics and Microfluidics
    • 3.5.6: Electrophoresis and Microfluidics
    • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Microfluidics Markets by Region
  • 4.2: North American Microfluidics Markets
    • 4.2.3: North American Microfluidics Markets by Application: Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics, and Others
  • 4.3: European Microfluidics Markets
    • 4.3.1: European Microfluidics Markets by Technology: Medical/Healthcare and Non-medical
    • 4.3.2: European Microfluidics Markets by Application: Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics, and Others
  • 4.4: APAC Microfluidics Markets
    • 4.4.1: APAC Microfluidics Markets by Technology: Medical/Healthcare and Non-medical
    • 4.4.2: APAC Microfluidics Markets by Application: Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics, and Others
  • 4.5: ROW Microfluidics Markets
    • 4.5.1: ROW Microfluidics Markets by Technology: Medical/Healthcare and Non-medical
    • 4.5.2: ROW Microfluidics Markets by Application: Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Microfluidics Markets by Technology
    • 6.1.2: Growth Opportunities for the Global Microfluidics Markets by Material
    • 6.1.3: Growth Opportunities for the Global Microfluidics Markets by Application
    • 6.1.4: Growth Opportunities for the Global Microfluidics Markets by Region
  • 6.2: Emerging Trends in the Global Microfluidics Markets
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Microfluidics Markets
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microfluidics Markets
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1:Illumina
  • 7.2: F. Hoffmann-La Roche
  • 7.3: PerkinElmer
  • 7.4: Agilent Technologies
  • 7.5: Bio-Rad Laboratories
  • 7.6: Danaher Corporation
  • 7.7: Abbott
  • 7.8: Thermo Fisher Scientific
  • 7.9: Standard BioTools